Drugs Made In America Acquisition (DMAAR) Total Current Liabilities (2024 - 2025)
Drugs Made In America Acquisition (DMAAR) posted Total Current Liabilities of $376172.0 for Q4 2025, down 17.62% on a QoQ basis from $456611.0 in Q3 2025, and down 52.72% year-over-year from $795669.0 in Q4 2024.
Drugs Made In America Acquisition (DMAAR) Total Current Liabilities (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition's Total Current Liabilities history runs 2 years deep, the most recent figure standing at $376172.0 for Q4 2025.
- Quarterly Total Current Liabilities fell 52.72% year-over-year to $376172.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $376172.0 (down 52.72% YoY) and the FY2025 annual result came in at $376172.0, down 52.72% from the prior year.
- Total Current Liabilities was $376172.0 for Q4 2025 at Drugs Made In America Acquisition, down from $456611.0 in the prior quarter.
- Across five years, Total Current Liabilities topped out at $795669.0 in Q4 2024 and bottomed at $301441.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - | 768,221.00 |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - | 155,510.00 |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - | 127,122.00 |
| 4 | Dynamix | 178.78 Mn | 178.78 Mn | - | 3.69 Mn |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - | 176,636.00 |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - | 1.29 Mn |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - | 3.69 Mn |
| 8 | Archimedes Tech SPAC Partners | 89.88 Mn | 89.88 Mn | - | 137,516.00 |
| 9 | Cohen Circle Acquisition | 80.05 Mn | 80.05 Mn | - | 152,324.00 |
| 10 | Drugs Made In America Acquisition | 1.46 Mn | 1.46 Mn | - | 376,172.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 376,172.00 |
| Sep 30, 2025 | 456,611.00 |
| Jun 30, 2025 | 301,441.00 |
| Mar 31, 2025 | 347,369.00 |
| Dec 31, 2024 | 795,669.00 |